Roth Capital analyst Bill Kirk lowered the firm’s price target on Albertsons (ACI) to $23 from $24 and keeps a Buy rating on the shares. The company delivered Q4 earnings driven by cost savings, productivity, and a shift toward generics in Pharmacy, the analyst tells investors in a research note. Roth adds it is seeing early signs of upside potential as EBITDA turned to y/y growth after 12 consecutive quarters of y/y decline, and the firm has confidence that efficiency programs will offset labor inflation and support reinvestment.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACI:
- Ex-Dividend Date Nearing for These 10 Stocks – Week of April 20, 2026
- Albertsons Media Collective launches onsite incrementality measurement
- Albertsons price target lowered to $20 from $23 at UBS
- Albertsons price target lowered to $20 from $21 at RBC Capital
- JPMorgan cuts Albertsons target, removes from Analyst Focus List